Prieels Pharma: what changed
What changed
Prieels Pharma
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€73,832
2024 · €13,861+€59,972
Equity
€114,791
2024 · €40,959+€73,832
Cash
€44,958
2024 · €234,175-€189,216
Balance sheet total
€1.3m
2024 · €275,867+€1.0m
Largest movements
Assets
- Financial fixed assets +€1.2m
new in 2025: €1.2m
- Cash -€189,216
down €189,216 (-80.8%), from €234,175 to €44,958
mainly Investment in fixed assets (net) (-€1.2m)
- Receivables within one year -€19,473
down €19,473 (-48.1%), from €40,510 to €21,036
of which Trade receivables: -€14,899
Equity and liabilities
- Debts after one year +€821,356
up €821,356 (+365%), from €225,000 to €1.0m
- Reserves +€85,000
up €85,000 (+341%), from €24,931 to €109,931
- Current portion of long-term debt +€68,090
new in 2025: €68,090
- Tax, wage and social debts +€27,907
up €27,907 (+346%), from €8,056 to €35,963
- Other debts +€20,085
up €20,085 (+2,411%), from €833 to €20,918
Income statement
- Gross operating margin +€110,886
up €110,886 (+583%), from €19,028 to €129,913
- Financial charges +€34,301
up €34,301 (+57,168%), from €60 to €34,361
- Taxes +€16,446
up €16,446 (+357%), from €4,606 to €21,052
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€13,861
Gross operating margin
+€110,886
Other operating charges
-€29
Financial income
-€138
Financial charges
-€34,301
Taxes
-€16,446
Result 2025
€73,832
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€142,239
Investment
-€1.2m
Financing
+€889,446
Cash 2024
€234,175
From operations (derived)
+€142,239
Net result for the year
+€73,832
Depreciation
+€339
Receivables within one year
+€19,473
Smaller working-capital items
+€603
Tax, wage and social debts
+€27,907
Other debts
+€20,085
Investment (derived)
-€1.2m
Investment in fixed assets (net)
-€1.2m
Financing
+€889,446
Debts after one year
+€821,356
Current portion of long-term debt
+€68,090
Cash 2025
€44,958
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €275,867 | €1,287,435 | +€1.0m | +367% |
| Fixed assets | 21/28 | €546 | €1,221,109 | +€1.2m | +223,460% |
| Tangible fixed assets | 22/27 | €546 | €208 | -€339 | -62.0% |
| Plant, machinery and equipment | 23 | - | €208 | +€208 | |
| Furniture and vehicles | 24 | €546 | - | -€546 | |
| Financial fixed assets | 28 | - | €1,220,901 | +€1.2m | |
| Current assets | 29/58 | €275,321 | €66,326 | -€208,996 | -75.9% |
| Amounts receivable within one year | 40/41 | €40,510 | €21,036 | -€19,473 | -48.1% |
| Trade receivables | 40 | €35,469 | €20,570 | -€14,899 | -42.0% |
| Other amounts receivable | 41 | €5,041 | €466 | -€4,574 | -90.7% |
| Cash at bank and in hand | 54/58 | €234,175 | €44,958 | -€189,216 | -80.8% |
| Deferred charges and accrued income | 490/1 | €637 | €331 | -€306 | -48.1% |
| Total equity and liabilities | 10/49 | €275,867 | €1,287,435 | +€1.0m | +367% |
| Equity | 10/15 | €40,959 | €114,791 | +€73,832 | +180% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €24,931 | €109,931 | +€85,000 | +341% |
| Distributable reserves | 133 | €24,931 | €109,931 | +€85,000 | +341% |
| Profit (loss) carried forward | 14 | €13,028 | €1,860 | -€11,168 | -85.7% |
| Amounts payable | 17/49 | €234,909 | €1,172,644 | +€937,735 | +399% |
| Amounts payable after more than one year | 17 | €225,000 | €1,046,356 | +€821,356 | +365% |
| Financial debts | 170/4 | €225,000 | €1,046,356 | +€821,356 | +365% |
| Amounts payable within one year | 42/48 | €9,896 | €126,198 | +€116,302 | +1,175% |
| Current portion of amounts payable after more than one year | 42 | - | €68,090 | +€68,090 | |
| Trade debts | 44 | €1,006 | €1,227 | +€221 | +21.9% |
| Suppliers | 440/4 | €1,006 | €1,227 | +€221 | +21.9% |
| Taxes, remuneration and social security | 45 | €8,056 | €35,963 | +€27,907 | +346% |
| Taxes | 450/3 | €8,056 | €35,963 | +€27,907 | +346% |
| Other amounts payable | 47/48 | €833 | €20,918 | +€20,085 | +2,411% |
| Accrued charges and deferred income | 492/3 | €13 | €89 | +€76 | +581% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €339 | €339 | = | 0.0% |
| Other operating charges | 640/8 | €443 | €472 | +€29 | +6.6% |
| Gross operating margin | 9900 | €19,028 | €129,913 | +€110,886 | +583% |
| Operating profit (loss) | 9901 | €18,247 | €129,103 | +€110,857 | +608% |
| Financial income | 75/76B | €280 | €142 | -€138 | -49.3% |
| Recurring financial income | 75 | €280 | €142 | -€138 | -49.3% |
| Financial charges | 65/66B | €60 | €34,361 | +€34,301 | +57,168% |
| Recurring financial charges | 65 | €60 | €34,361 | +€34,301 | +57,168% |
| Profit (loss) for the period before taxes | 9903 | €18,466 | €94,884 | +€76,418 | +414% |
| Income taxes | 67/77 | €4,606 | €21,052 | +€16,446 | +357% |
| Profit (loss) for the period | 9904 | €13,861 | €73,832 | +€59,972 | +433% |
| Profit (loss) for the period to be appropriated | 9905 | €13,861 | €73,832 | +€59,972 | +433% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.